Skip to Main Content

Paper Details

Value of [<sup>18</sup>F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab.
Neurooncol Adv
2
2020
Author NameAffiliation
Zhigang ZhangMemorial Sloan Kettering Cancer Center
Thomas J KaleyMemorial Sloan Kettering Cancer Center
Thomas J KaleyMemorial Sloan Kettering Cancer Center
  • 1 - 3

Datasets

Release 1.2